Science and Technology Facilities Council
STFC-funded science maps targets for COVID-19 antibodies
An international team of scientists has identified how antibodies interact with and neutralise the virus that causes COVID using the UK’s national synchrotron.
The team used X-ray crystallography and cryo-electron microscopy techniques to map the interactions between antibodies and the SARS-CoV-2 virus at Diamond Light Source, giving scientists the tools to find many different ways to neutralise the virus.
Diamond Light Source is funded by the Science and Technology Facilities Council (STFC) and the Wellcome Trust.
Mapping the virus
The team examined antibodies from a large cohort of COVID-19 patients to discover more about the different ways in which antibodies can target the distinctive spike protein on the surface of the SARS-CoV-2 virus and prevent the virus from interacting with receptors in human cells.
Professor Sir Dave Stuart, Life Sciences Director at Diamond and Joint head of Structural Biology at the University of Oxford, recently said:
By using Diamond Light Source, applying X-ray crystallography and cryo-EM, we were able to visualise and understand how antibodies interact with and neutralise the virus.
The study narrowed down the 377 antibodies that recognise the spike to focus mainly on 80 of them that bound to the receptor-binding domain of the virus, which is where the virus spike docks with human cells.
The results of the study, published in Cell on 15 April, allowed the team to build a detailed map of where antibodies were able to attach to the spike protein.
The research revealed that neutralising antibodies attach to the binding site for the receptor in similar ways for many people.
Dr Helen Ginn, Post-Doctoral Research Assistant at Diamond Light Source recently said:
The receptor-binding domain resembles a human torso. During this extensive study on 80 antibodies, we have discovered weak points at five different areas on the torso. The weak points can be found running between the left shoulder and neck, on the right shoulder, down the right flank and on the left flank.
This study provides important information to the scientific community who are looking to increase the tools that we have available to fight the virus.
The new mapping method developed by the scientific team could also be used to provide roadmaps for understanding weakness in other viral diseases.
Read the paper in full:
Authors: Wanwisa Dejnirattisai, Daming Zhou, Helen M. Ginn, Jingshan Ren,
David I. Stuart, Gavin R. Screaton.
Latest News from
Science and Technology Facilities Council
Taking another look at a cancer culprit29/04/2021 10:05:00
Researchers at STFC have gained new insights into the behaviour of a cancer-causing protein, which could pave the way for new cancer therapies.
Forging a new partnership with South Africa27/04/2021 15:05:00
The Science and Technology Facilities Council (STFC) has strengthened its ties with scientific peers in South Africa.
STFC invests in next generation of science leaders26/04/2021 12:05:00
The Science and Technology Facilities Council (STFC) has awarded £5.7 million of funding to support the next generation of science leaders.
Evidence of new physics in highly-anticipated g-2 results08/04/2021 11:05:00
A much-anticipated result from an international science experiment provides strong evidence for the existence of an undiscovered subatomic particle or new force.
UKRI councils are moving to ukri.org – and we need your input29/03/2021 10:05:00
Starting early this summer and throughout the year the nine council websites are moving to the new integrated UKRI site. Your input will help us shape our new home.
UK joins European network to advance high performance computing22/03/2021 12:43:00
Two leading supercomputing facilities in the UK have combined to create a national computing competence centre as part of a Europe-wide network.
UK scientists help plan for the effects of solar storms on Earth17/03/2021 13:05:00
UK scientists have set out how the government can prepare for space weather events, which could impact multiple critical infrastructures in a short space of time.
UK start-ups collaborate in the fight against COVID-1911/03/2021 13:05:00
Two biotech start-ups at Daresbury Laboratory have developed a new type of COVID-19 testing platform that is rapid, low cost and easy to use.